Follow
“The major advantage of NK cells is they’ve never killed anybody, unlike CAR-T cells,” says Lewis Lanier of the University of California, San Francisco, and the Parker Institute of Cancer Immunotherapy, who has pioneered research into the NK cell biology over the past 40 years. For reasons that are not fully understood, cytokine release syndrome, if it occurs during NK cell therapy, tends to be much milder.'
